Results 171 to 180 of about 3,364,352 (377)

Optimizing Patient Registries for Regulatory Decision Making ‐ Key Learnings From an HMA/EMA Multistakeholder Workshop

Clinical Pharmacology &Therapeutics, EarlyView.
The Joint Heads of Medicines Agencies and European Medicines Agency's (HMA/EMA) big data initiative paves the way for better integration of real‐world data, including data from patient registries, into regulatory decisions on medicines. This article focuses on the outcome of a two‐day multistakeholder workshop organized by EMA in 2024, which explored ...
Kelly Plueschke, Carla Jonker, Hanna Kankanen, Thorsten Vetter, Bruno Sepodes, Lutz Naehrlich, Jan Hillert, Gracy Crane, Sabine Straus, Paolo Foggi, Simona Martin, Christina Kyriakopoulou, Peter Mol, Francesca Day, Kieran Breen, Neil Bennett, Mencia de Lemus Belmonte, Simon Bennett, Patrice Verpillat, Kit C. B. Roes, Ana Cochino, Franz Schaefer, Jesús María Hernández‐Rivas, Patricia McGettigan, Peter Arlett   +24 more
wiley   +1 more source

NEUROMUSCULAR BLOCKING AGENTS

British Journal of Anaesthesia, 1962
W.D.M. Paton, D.R. Ward
openaire   +3 more sources

MODE OF ACTION OF NEUROMUSCULAR BLOCKING AGENTS * *A paper given at the World Congress of Anaesthesiologists, Scheveningen, Holland, in September 1955.

, 1956
W. D. M. Paton
openalex   +1 more source

The nicotinic blocking agents d-tubocurare and alpha-bungarotoxin save motoneurons from naturally occurring death in the absence of neuromuscular blockade [PDF]

, 1995
F Hory-Lee, E Frank
openalex   +1 more source

The endocannabinoid system regulates both ependymoglial and neuronal cell responses to a tail amputation in the axolotl

Developmental Dynamics, EarlyView.
Abstract Background The endocannabinoid system is a neuromodulatory system implicated in cellular processes during both development and regeneration. The Mexican axolotl, one of only a few vertebrates capable of central nervous system regeneration, was used to examine the role of the endocannabinoid system in the regeneration of the tail and spinal ...
Michael Tolentino, Sarah E. Walker, Gaynor E. Spencer, Robert Carlone   +3 more
wiley   +1 more source

Recent advances in neuromuscular blocking agents [PDF]

, 1999
RR Bartkowski
openalex   +1 more source

Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

ESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai, Minoru Yasukawa, Shigeru Shibata   +2 more
wiley   +1 more source

Tetanus : forgiven, not forgotten [PDF]

, 2004
Tetanus is an illness that is still prevalent although the incidence has markedly decreased largely due to immunisation programmes. The latest four cases managed at St. Luke's hospital over 2001-2002 are presented. All of these patients survived. We give
Mallia Azzopardi, Charles, Piscopo, Tonio V.   +1 more
core  

THE INFLUENCE OF CERTAIN GANGLIONIC BLOCKING AGENTS ON NEUROMUSCULAR TRANSMISSION

, 1962
A. R. de C. Deacock, Richard Hargrove
openalex   +1 more source

Pharmacoeconomic issues related to selection of neuromuscular blocking agents [PDF]

, 1999
P F White
openalex   +1 more source